The cost of asthma control
Chotirmall, Sanjay Haresh
Date of Issue2017
Lee Kong Chian School of Medicine
Asthma care has advanced signiﬁcantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in Europe; however, emerging trends and ageing populations in Asia mean that disease burden is likely to rise. Early work published over a decade ago suggests that levels of asthma control within the Asia-Paciﬁc were short of that expected from international guidelines. Recent data derived from the Asia-Paciﬁc Asthma Insights and Management (AIM) survey reveal some potential explanations: more than half of all participants reported completely or well-controlled asthma but concurrently two-thirds admitted to an exacerbation averaging 5 days and missed work or school time. This discordance in understanding asthma control among Asian patients is further evidenced by data from the REcognise Asthma and LInk to Symptoms and Experience (REALISE) Study that assessed perception of asthma control and attitudes towards treatment in 2467 patients in a real-life setting. Patients were found to consistently overestimate their levels of asthma control contrary to symptoms and critically found to perceive the management of exacerbations as a control measure.
© 2017 Asian Pacific Society of Respirology. This is the author created version of a work that has been peer reviewed and accepted for publication by Respirology, Asian Pacific Society of Respirology. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1111/resp.12991].